Letybo Earns FDA Approval, Hugel Expands Its Global Aesthetic Market Leadership
XTalks
JUNE 17, 2024
This is a huge achievement for Hugel as we focus on becoming a top aesthetics brand in the US,” said James Hartman, president of Hugel America in the news release. “As Among the most widely sought-after options are botulinum toxin injections, commonly referred to as Botox or Dysport. “We are thrilled with the FDA’s approval of Letybo.
Let's personalize your content